The analysis also examines water use and offers a road map for lower emissions through states with considerable renewable resources.

A new study involving risk modelers shows that mangrove forests protect Florida's coast and could help reduce property-insurance rates.

A handful of congressional Democrats may be the only U.S. federal elected officials going to Brazil.

Residents question whether the villages can survive in the face of rising seas, erosion, melting permafrost and worsening storms.

Governments — typically developing nations — use swaps to refinance debt and direct savings toward environmental projects.

The city of 9 million's reservoirs have fallen to their lowest level in 60 years.

The island country is also set to get coverage in the form of prearranged credits and parametric insurance.

Nature Climate Change, Published online: 10 November 2025; doi:10.1038/s41558-025-02485-w

Using population and ecological genomic approaches, the authors demonstrate the potential for interspecific introgression—the transfer of genetic material following hybridization—to reduce climate change vulnerability. Their findings emphasize the importance of preserving interspecific connectivity.

The second season of the Netflix reality competition show Squid Game: The Challenge has dropped. (Too many links to pick a few—search for it.)

As usual, you can also use this squid post to talk about the security stories in the news that I haven’t covered.

Blog moderation policy.

With global power demand from data centers expected to more than double by 2030, the MIT Energy Initiative (MITEI) in September launched an effort that brings together MIT researchers and industry experts to explore innovative solutions for powering the data-driven future. At its annual research conference, MITEI announced the Data Center Power Forum, a targeted research effort for MITEI member companies interested in addressing the challenges of data center power demand. The Data Center Power Forum builds on lessons from MITEI’s May 2025 symposium on the energy to power the expansion of artificial intelligence (AI) and focus panels related to data centers at the fall 2024 research conference.

In the United States, data centers consumed 4 percent of the country’s electricity in 2023, with demand expected to increase to 9 percent by 2030, according to the Electric Power Research Institute. Much of the growth in demand is from the increasing use of AI, which is placing an unprecedented strain on the electric grid. This surge in demand presents a serious challenge for the technology and energy sectors, government policymakers, and everyday consumers, who may see their electric bills skyrocket as a result.

“MITEI has long supported research on ways to produce more efficient and cleaner energy and to manage the electric grid. In recent years, MITEI has also funded dozens of research projects relevant to data center energy issues. Building on this history and knowledge base, MITEI’s Data Center Power Forum is convening a specialized community of industry members who have a vital stake in the sustainable growth of AI and the acceleration of solutions for powering data centers and expanding the grid,” says William H. Green, the director of MITEI and the Hoyt C. Hottel Professor of Chemical Engineering.

MITEI’s mission is to advance zero- and low-carbon solutions to expand energy access and mitigate climate change. MITEI works with companies from across the energy innovation chain, including in the infrastructure, automotive, electric power, energy, natural resources, and insurance sectors. MITEI member companies have expressed strong interest in the Data Center Power Forum and are committing to support focused research on a wide range of energy issues associated with data center expansion, Green says.

MITEI’s Data Center Power Forum will provide its member companies with reliable insights into energy supply, grid load operations and management, the built environment, and electricity market design and regulatory policy for data centers. The forum complements MIT’s deep expertise in adjacent topics such as low-power processors, efficient algorithms, task-specific AI, photonic devices, quantum computing, and the societal consequences of data center expansion. As part of the forum, MITEI’s Future Energy Systems Center is funding projects relevant to data center energy in its upcoming proposal cycles. MITEI Research Scientist Deep Deka has been named the program manager for the forum.

“Figuring out how to meet the power demands of data centers is a complicated challenge. Our research is coming at this from multiple directions, from looking at ways to expand transmission capacity within the electrical grid in order to bring power to where it is needed, to ensuring the quality of electrical service for existing users is not diminished when new data centers come online, and to shifting computing tasks to times and places when and where energy is available on the grid," said Deka.

MITEI currently sponsors substantial research related to data center energy topics across several MIT departments. The existing research portfolio includes more than a dozen projects related to data centers, including low- or zero-carbon solutions for energy supply and infrastructure, electrical grid management, and electricity market policy. MIT researchers funded through MITEI’s industry consortium are also designing more energy-efficient power electronics and processors and investigating behind-the-meter low-/no-carbon power plants and energy storage. MITEI-supported experts are studying how to use AI to optimize electrical distribution and the siting of data centers and conducting techno-economic analyses of data center power schemes. MITEI’s consortium projects are also bringing fresh perspectives to data center cooling challenges and considering policy approaches to balance the interests of shareholders. 

By drawing together industry stakeholders from across the AI and grid value chain, the Data Center Power Forum enables a richer dialog about solutions to power, grid, and carbon management problems in a noncommercial and collaborative setting.

“The opportunity to meet and to hold discussions on key data center challenges with other forum members from different sectors, as well as with MIT faculty members and research scientists, is a unique benefit of this MITEI-led effort,” Green says.

MITEI addressed the issue of data center power needs with its company members during its fall 2024 Annual Research Conference with a panel session titled, “The extreme challenge of powering data centers in a decarbonized way.” MITEI Director of Research Randall Field led a discussion with representatives from large technology companies Google and Microsoft, known as “hyperscalers,” as well as Madrid-based infrastructure developer Ferrovial S.E. and utility company Exelon Corp. Another conference session addressed the related topic, “Energy storage and grid expansion.” This past spring, MITEI focused its annual Spring Symposium on data centers, hosting faculty members and researchers from MIT and other universities, business leaders, and a representative of the Federal Energy Regulatory Commission for a full day of sessions on the topic, “AI and energy: Peril and promise.” 

Over the past few decades, it’s become easier and easier to create fake receipts. Decades ago, it required special paper and printers—I remember a company in the UK advertising its services to people trying to cover up their affairs. Then, receipts became computerized, and faking them required some artistic skills to make the page look realistic.

Now, AI can do it all:

Several receipts shown to the FT by expense management platforms demonstrated the realistic nature of the images, which included wrinkles in paper, detailed itemization that matched real-life menus, and signatures...

The market lets countries fund climate projects and could trigger billions of dollars in investments for cutting emissions.

Dominion Energy spent more than $3 million to try to keep Democrat Jay Jones out of office.

Republicans from Montana to Mississippi have embraced the Biden administration’s push to expand passenger rail nationwide.

The pilot facility planned by Avnos would use direct air capture technology that also pulls moisture from the sky.

The U.K. prime minister is heading to the COP30 climate summit in Brazil to show climate still matters Britain, even in the age of Trump. But back at home, Starmer blows hot and cold on all things green.

Grace Fu said the atmosphere in Belém is “more positive than we had expected.”

A push to slash red tape drives an ever-bigger wedge between Europe’s traditional centrist coalition.

The directive is intended to force companies to provide climate transition plans and exposes them to penalties if they don't address human rights violations in their value chains.

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.

In studies in mice, the researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune response as mRNA delivered by nanoparticles made with FDA-approved materials, but at around 1/100 the dose.

“One of the challenges with mRNA vaccines is the cost,” says Daniel Anderson, a professor in MIT’s Department of Chemical Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES). “When you think about the cost of making a vaccine that could be distributed widely, it can really add up. Our goal has been to try to make nanoparticles that can give you a safe and effective vaccine response but at a much lower dose.”

While the researchers used their particles to deliver a flu vaccine, they could also be used for vaccines for Covid-19 and other infectious diseases, they say.

Anderson is the senior author of the study, which appears today in Nature Nanotechnology. The lead authors of the paper are Arnab Rudra, a visiting scientist at the Koch Institute; Akash Gupta, a Koch Institute research scientist; and Kaelan Reed, an MIT graduate student.

Efficient delivery

To protect mRNA vaccines from breaking down in the body after injection, they are packaged inside a lipid nanoparticle, or LNP. These fatty spheres help mRNA get into cells so that it can be translated into a fragment of a protein from a pathogen such as influenza or SARS-CoV-2.

In the new study, the MIT team sought to develop particles that can induce an effective immune response, but at a lower dose than the particles now used to deliver Covid-19 mRNA vaccines. That could not only reduce the costs per vaccine dose, but may also help to lessen the potential side effects, the researchers say.

LNPs typically consist of five elements: an ionizable lipid, cholesterol, a helper phospholipid, a polyethylene glycol lipid, and mRNA. In this study, the researchers focused on the ionizable lipid, which plays a key role in vaccine strength.

Based on their knowledge of chemical structures that might improve delivery efficiency, the researchers designed a library of new ionizable lipids. These contained cyclic structures, which can help enhance mRNA delivery, as well as chemical groups called esters, which the researchers believed could also help improve biodegradability.

The researchers then created and screened many combinations of these particle structures in mice to see which could most effectively deliver the gene for luciferase, a bioluminescent protein. Then, they took their top-performing particle and created a library of new variants, which they tested in another round of screening.

From these screens, the top LNP that emerged is one that the researchers called AMG1541. One key feature of these new LNPs is that they are more effective in dealing with a major barrier for delivery particles, known as endosomal escape. After LNPs enter cells, they are isolated in cellular compartments called endosomes, which they need to break out of to deliver their mRNA. The new particles did this more effectively than existing LNPs.

Another advantage of the new LNPs is that the ester groups in the tails make the particles degradable once they have delivered their cargo. This means they can be cleared from the body quickly, which the researchers believe could reduce side effects from the vaccine.

More powerful vaccines

To demonstrate the potential applications of the AMG1541 LNP, the researchers used it to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with a lipid called SM-102, which is FDA-approved and was used by Moderna in its Covid-19 vaccine.

Mice vaccinated with the new particles generated the same antibody response as mice vaccinated with the SM-102 particle, but only 1/100 of the dose was needed to generate that response, the researchers found.

“It’s almost a hundredfold lower dose, but you generate the same amount of antibodies, so that can significantly lower the dose. If it translates to humans, it should significantly lower the cost as well,” Rudra says.

Further experiments revealed that the new LNPs are better able to deliver their cargo to a critical type of immune cells called antigen-presenting cells. These cells chop up foreign antigens and display them on their surfaces, which signals other immune cells such as B and T cells to become activated against that antigen.

The new LNPs are also more likely to accumulate in the lymph nodes, where they encounter many more immune cells.

Using these particles to deliver mRNA flu vaccines could allow vaccine developers to better match the strains of flu that circulate each winter, the researchers say. “With traditional flu vaccines, they have to start being manufactured almost a year ahead of time,” Reed says. “With mRNA, you can start producing it much later in the season and get a more accurate guess of what the circulating strains are going to be, and it may help improve the efficacy of flu vaccines.”

The particles could also be adapted for vaccines for Covid-19, HIV, or any other infectious disease, the researchers say.

“We have found that they work much better than anything that has been reported so far. That’s why, for any intramuscular vaccines, we think that our LNP platforms could be used to develop vaccines for a number of diseases,” Gupta says.

The research was funded by Sanofi, the National Institutes of Health, the Marble Center for Cancer Nanomedicine, and the Koch Institute Support (core) Grant from the National Cancer Institute.